Ladenburg Thalmann Financial Services’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | $240K | Sell |
3,031
-1,109
| -27% | -$87.8K | ﹤0.01% | 2370 |
|
|
2019
Q3 | $202K | Sell |
4,140
-828
| -17% | -$40.4K | ﹤0.01% | 2457 |
|
|
2019
Q2 | $261K | Buy |
4,968
+4,888
| +6,110% | +$257K | ﹤0.01% | 2262 |
|
|
2019
Q1 | $4K | Sell |
80
-2
| -2% | -$100 | ﹤0.01% | 4781 |
|
|
2018
Q4 | $3K | Sell |
82
-350
| -81% | -$12.8K | ﹤0.01% | 4823 |
|
|
2018
Q3 | $17K | Buy |
432
+152
| +54% | +$5.98K | ﹤0.01% | 4015 |
|
|
2018
Q2 | $14K | Hold |
280
| – | – | ﹤0.01% | 4068 |
|
|
2018
Q1 | $14K | Sell |
280
-5,800
| -95% | -$290K | ﹤0.01% | 4068 |
|
|
2017
Q4 | $239K | Buy |
6,080
+5,980
| +5,980% | +$235K | ﹤0.01% | 2080 |
|
|
2017
Q3 | $3K | Hold |
100
| – | – | ﹤0.01% | 4606 |
|
|
2017
Q2 | $3K | Buy |
+100
| New | +$3K | ﹤0.01% | 4517 |
|